MGH AF Study: Exome Sequencing in Early-Onset Atrial Fibrillation

This substudy phs001117 Massachusetts General Hospital (MGH) AF Study: Exome Sequencing Study includes exome sequencing for subjects with early-onset atrial fibrillation. Summary level phenotypes for the Massachusetts General Hospital (MGH) Atrial Fibrillation (AF) Study participants can be viewed at the top-level study page http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001001MGH AF Study. Individual level phenotype data and molecular data for all MGH AF top-level study and substudies are available by requesting Authorized Access to the MGH AF Study http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001001. The Massachusetts General Hospital (MGH) Atrial Fibrillation Study was initiated in 2001. The study has enrolled serial probands, unaffected and affected family members with atrial fibrillation. At enrollment participants undergo a structured interview to systematically capture their past medical history... (for more see dbGaP study page.)